Shattuck Labs Inc
STTK
NASDAQ
Biotechnology
$7.42
USD
+0.10 (+1.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $661.53M
Volume 640.7K
Revenue
$1.00M
TTM
-66.6%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-52.57M
TTM
+14.5%
YoY
Operating Cash Flow
$-41.03M
TTM
+26.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -100.0% | -66.6% | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 4.4 | 4.1 | 4.3 | 4.6 | 4.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 13.0 | 11.7 | 13.4 | 15.5 | 16.2 |
Operating Income | -13.0 | -10.7 | -13.4 | -15.5 | -16.2 |
EBITDA | -12.1 | -9.8 | -12.5 | -14.7 | -15.3 |
Other Income / Expense | -0.2 | 0.7 | -1.9 | -0.0 | -0.0 |
Total Other Income / Expense | 0.6 | 0.7 | 0.8 | 0.8 | 1.0 |
Income Before Income Taxes | -12.5 | -10.1 | -12.6 | -14.8 | -15.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -12.5 | -10.1 | -12.6 | -14.8 | -15.2 |
Consolidated Net Income / Loss | -12.5 | -10.1 | -12.6 | -14.8 | -15.2 |
Net Income Attributable to Common Shareholders | -12.5 | -10.1 | -12.6 | -14.8 | -15.2 |
Basic EPS | -$0.24 | -$0.14 | -$0.12 | -$0.13 | -$0.12 |
Diluted EPS | -$0.24 | -$0.14 | -$0.12 | -$0.13 | -$0.12 |
Basic Shares Outstanding | 51.0M | 72.2M | 104.2M | 112.2M | 129.8M |
Diluted Shares Outstanding | 51.0M | 72.2M | 104.2M | 112.2M | 129.8M |